Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Healthcare Cannabis
Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.


TSX:WEED - Post by User

Canopy Growth Corp > Pro - Canopy traders
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(49)
•••
Comment by Apprenticeon Mar 25, 2024 9:19am
69 Views
Post# 35950364

RE:RE:RE:Pro - Canopy traders

RE:RE:RE:Pro - Canopy traders

Dreamers?

Statista

  • Furthermore, a promising annual growth rate of 14.15% (CAGR 2024-2028) is anticipated, which will result in a market volume of US$7.98bn by 2028.
  • When comparing Canada's performance with other countries, it is noteworthy that in the United States is expected to generate the highest revenue in the Cannabis market, reaching an impressive US$39,850.00m by 2024.

 

TD Cowen

The multinational investment firm TD Cowen said last month it projects legal cannabis sales will reach $37 billion in 2027, up from what it said was about $29 billion in 2023. At least some of that growth is expected to come from increased substitution of cannabis for alcohol, particularly among younger adults.



https://x.com/marijuanamoment/status/1772231105279623356?s=46

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities